[go: up one dir, main page]

ES2181793T3 - Diazepino-indoles como inhibidores de fosfodiesterasas iv. - Google Patents

Diazepino-indoles como inhibidores de fosfodiesterasas iv.

Info

Publication number
ES2181793T3
ES2181793T3 ES95935495T ES95935495T ES2181793T3 ES 2181793 T3 ES2181793 T3 ES 2181793T3 ES 95935495 T ES95935495 T ES 95935495T ES 95935495 T ES95935495 T ES 95935495T ES 2181793 T3 ES2181793 T3 ES 2181793T3
Authority
ES
Spain
Prior art keywords
hydrogen
racemic forms
indolyl
haloalkyl
configuration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935495T
Other languages
English (en)
Inventor
Yves Pascal
Indres Moodley
Alain Calvet
Jean-Louis Junien
Svein G Dahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Holding France SCA
Original Assignee
Pfizer Holding France SCA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Holding France SCA filed Critical Pfizer Holding France SCA
Application granted granted Critical
Publication of ES2181793T3 publication Critical patent/ES2181793T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

APLICACION DE DERIVADOS DE DIACEPINOINDOLES DE FORMULA (I), EN LA QUE: R ES HIDROGENO, ALQUILO INFERIOR, ALCOXI INFERIOR; A ES ARILO O HETEROARILO MONO - A TRISUSTITUIDO, SUS FORMAS RACEMICAS, SUS ENANTIOMEROS, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, QUE COMPRENDEN NUEVOS PRODUCTOS, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE LAS AFECCIONES QUE REQUIEREN UNA TERAPIA POR LOS INHIBIDORES DE FOSFODIESTERASAS IV.
ES95935495T 1994-10-14 1995-10-13 Diazepino-indoles como inhibidores de fosfodiesterasas iv. Expired - Lifetime ES2181793T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412282A FR2725719B1 (fr) 1994-10-14 1994-10-14 Diazepino-indoles inhibiteurs de phosphodiesterases iv

Publications (1)

Publication Number Publication Date
ES2181793T3 true ES2181793T3 (es) 2003-03-01

Family

ID=9467863

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935495T Expired - Lifetime ES2181793T3 (es) 1994-10-14 1995-10-13 Diazepino-indoles como inhibidores de fosfodiesterasas iv.

Country Status (24)

Country Link
US (1) US5852190A (es)
EP (1) EP0785789B1 (es)
JP (1) JPH10507447A (es)
KR (1) KR970706826A (es)
CN (1) CN1097459C (es)
AT (1) ATE223720T1 (es)
AU (1) AU703773B2 (es)
BR (1) BR9509353A (es)
CA (1) CA2200628A1 (es)
CZ (1) CZ111497A3 (es)
DE (1) DE69528189T2 (es)
DK (1) DK0785789T3 (es)
ES (1) ES2181793T3 (es)
FR (1) FR2725719B1 (es)
HU (1) HUT77411A (es)
NO (1) NO971687L (es)
NZ (1) NZ294642A (es)
PL (1) PL319659A1 (es)
PT (1) PT785789E (es)
RU (1) RU2174517C2 (es)
SK (1) SK282766B6 (es)
UA (1) UA42793C2 (es)
WO (1) WO1996011690A1 (es)
ZA (1) ZA958669B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) * 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv
FR2776660B1 (fr) * 1998-03-27 2000-05-12 Parke Davis Diazepino-indoles de phosphodiesterases iv
CZ302882B6 (cs) 1999-08-21 2012-01-04 Nycomed Gmbh Farmaceutický prostredek
CA2395772C (en) * 1999-12-28 2010-09-28 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
BR0108908A (pt) * 2000-03-03 2002-12-24 Pfizer Prod Inc Derivados de éteres de pirazol como agentes antiinflamatórios/analgésicos
EP1161949A1 (en) 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
DE10148290A1 (de) 2001-09-29 2003-04-17 Bayer Cropscience Gmbh Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
BRPI0409229A (pt) 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
RU2378279C1 (ru) * 2008-05-28 2010-01-10 Государственное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) CПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ 1,2,3,6-ТЕТРАГИДРОПИРРОЛО[1,2-d][1,4]ДИАЗОЦИНОВ
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840947A (en) * 1986-10-14 1989-06-20 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic piperidin-4-yl-tetracyclic benzodiazepines and use thereas
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
CA2093797C (en) * 1990-10-10 1998-09-22 Richard J. Friary Substituted imidazobenzazepines and imidazopyridoazepines

Also Published As

Publication number Publication date
NZ294642A (en) 2001-06-29
FR2725719A1 (fr) 1996-04-19
KR970706826A (ko) 1997-12-01
RU2174517C2 (ru) 2001-10-10
DK0785789T3 (da) 2003-01-20
UA42793C2 (uk) 2001-11-15
AU3749495A (en) 1996-05-06
CA2200628A1 (fr) 1996-04-25
DE69528189T2 (de) 2003-01-09
CN1097459C (zh) 2003-01-01
HUT77411A (hu) 1998-04-28
WO1996011690A1 (fr) 1996-04-25
AU703773B2 (en) 1999-04-01
CZ111497A3 (cs) 1998-01-14
ATE223720T1 (de) 2002-09-15
NO971687L (no) 1997-06-13
US5852190A (en) 1998-12-22
EP0785789B1 (fr) 2002-09-11
DE69528189D1 (de) 2002-10-17
ZA958669B (en) 1997-04-14
PT785789E (pt) 2002-12-31
NO971687D0 (no) 1997-04-11
SK282766B6 (sk) 2002-12-03
MX9702637A (es) 1997-07-31
CN1160352A (zh) 1997-09-24
EP0785789A1 (fr) 1997-07-30
PL319659A1 (en) 1997-08-18
JPH10507447A (ja) 1998-07-21
SK44897A3 (en) 1998-12-02
FR2725719B1 (fr) 1996-12-06
BR9509353A (pt) 1997-12-30

Similar Documents

Publication Publication Date Title
ES2181793T3 (es) Diazepino-indoles como inhibidores de fosfodiesterasas iv.
EA200300265A1 (ru) Производные хиназолина в качестве ингибиторов киназы
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
ATE339409T1 (de) Trizyklische verbindungen
DE69406649D1 (de) N-alkyl-2-substituierte atp-analoge
WO2005041899A3 (en) Orally available sphingosine 1-phosphate receptor agonists and antagonists
HUP0002353A2 (hu) IV típusú foszfodiészteráz inhibitor hatású 1-cikloalkil-1,8-naftiridin-4-on-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
WO2007122634A3 (en) Pyrimidinediones as tyrosine kinase inhibitors
MY139887A (en) Tetrahydronaphthyridine derivatives and a process for preparing the same.
TW200745034A (en) New compounds
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
NZ505220A (en) Arylpiperazines having activity at the serotonin 1A receptor, processes for their preparation and intermediates
BRPI0414573A (pt) 7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas
WO2004004730A3 (en) 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders
DE60324685D1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren
MY143245A (en) 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
NO20032291L (no) Pyrimidinderivater
MXPA02011464A (es) Derivados 1,4-diazepan-2,5-diona y su uso como antagonistas del receptor de la nk-1.
EA200100816A1 (ru) 2-аминопиридины, содержащие конденсированные кольца в качестве заместителей
RU2001114213A (ru) Циклоалкилзамещенное производное аминометилпирролидина
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
HUP9903893A2 (hu) Eljárás szívelégtelenségnek ciklopentánnal kondenzált heterogyűrűs endotelin-antagonistákkal történő kezelésére
DE60000978D1 (de) 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
MY133207A (en) Substituted benzolactam compaunds
PT1140925E (pt) 3,4-di-hidro-2h-benzo¬1,4|oxazinil-metil-¬3-(1h-indol-3il)-alquil|-aminas